babitarani
New member
The high cost of neurology medicines in India is a complex issue influenced by various factors, including R&D expenses, patent protection, regulatory requirements, and supply chain dynamics. Addressing these challenges requires a multifaceted approach involving government policies, industry initiatives, and public awareness. By promoting domestic production, streamlining regulatory processes, expanding insurance coverage, and encouraging the use of generics, India can make neurology medicines more affordable and accessible to those in need.